American Association for the Advancement of Science, Science Translational Medicine, 580(13), 2021
DOI: 10.1126/scitranslmed.abd3438
Full text: Unavailable
Incorporating TLR9-inhibitory sequences in the AAV vector genome inhibits immunogenicity and enhances transgene expression in multiple animal models.